ProCE Banner Activity

EBCTCG Meta-analysis of Breast Cancer Recurrence and Survival Following Ovarian Ablation or Suppression in Premenopausal Women

Conference Coverage
Slideset

Meta-analysis of pooled data from nearly 15,000 premenopausal women with ER-positive breast cancer demonstrated reductions in breast cancer recurrence and cause-specific mortality with use of ovarian ablation or suppression.

Released: June 08, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Gilead and Merck Sharp & Dohme Corp.

AstraZeneca

Daiichi Sankyo

Gilead

Merck Sharp & Dohme Corp.